Breast Enhancement Surgery — Cost, Top Hospitals & Success Rates | MyMedicPlus

Breast enhancement surgery, clinically termed augmentation mammaplasty, is one of the most commonly performed elective cosmetic surgical procedures worldwide. It is designed to increase breast volume, improve breast shape, restore volume lost after pregnancy or weight loss, or correct natural asymmetry. The procedure involves placing implants beneath the breast tissue or chest muscle (pectoralis major), or using the patient's own fat (autologous fat transfer) to add volume. Approximately 1.8 million augmentation procedures are performed globally each year.

The procedure is performed under general anaesthesia and typically takes 60 to 90 minutes. The surgeon makes a small incision through which a pocket is created either above the pectoralis major (subglandular) or beneath it (submuscular or dual-plane), and the implant is placed. Modern implants come in a variety of shapes (round or anatomical teardrop), profiles, and surfaces (smooth or textured), allowing the surgeon to select the combination that best achieves the patient's desired outcome while maintaining a natural appearance.

Patients typically go home the same day or the following morning. A surgical bra is worn for several weeks. Most patients return to light work within five to seven days and to exercise within four to six weeks. Long-term, implants may require revision surgery — current third-generation cohesive silicone gel implants have ten-year revision rates of approximately 10 to 20% for various reasons including size change preference, capsular contracture, or rupture.

Breast enhancement surgery primarily addresses hypomastia — underdevelopment of the breasts — which can be congenital, constitutional (naturally small breast tissue for body proportions), or acquired following significant weight loss, multiple pregnancies, or breastfeeding-related volume loss. It is also used to restore breast symmetry in cases of natural size discrepancy between the two sides, which is common and can cause significant self-consciousness.

Beyond purely cosmetic indications, breast enhancement surgery has a reconstructive role. Patients who have undergone mastectomy for breast cancer or prophylactic mastectomy (BRCA mutation carriers) often choose implant-based reconstruction as part of breast-enhancement surgery. Patients with tuberous breast deformity — a congenital condition characterised by a constricted breast base, high fold, and inferior pole deficiency — may benefit from augmentation combined with reshaping techniques. The psychological benefits of correcting these concerns are well-documented, with improvements in body image, self-esteem, and quality of life reported in prospective studies.

Ideal candidates are women aged 18 or older (22 or older for silicone implants in some regulatory jurisdictions) who have realistic expectations, good general health, and stable weight. Candidates should be non-smokers or willing to cease smoking at least six weeks before and after surgery, as smoking significantly impairs wound healing and increases capsular contracture risk. Women who have completed childbearing or are aware that future pregnancy and breastfeeding may alter surgical results are better placed to make long-term decisions. Psychological stability and motivation from personal desire rather than external pressure are important.

Contraindications include active breast infection, untreated breast cancer or suspected malignancy, autoimmune connective tissue diseases that increase capsular contracture risk, unrealistic expectations, and severe body dysmorphic disorder. Relative contraindications include very thin skin with little native breast tissue (predisposing to visible implant edges and rippling), extremely ptotic (drooping) breasts that require concurrent mastopexy, and young patients who have not completed breast development.

Silicone gel implants are the preferred choice for most patients owing to their natural feel and reduced wrinkling compared with saline implants. Modern cohesive gel (gummy bear) implants maintain their shape even if the outer shell is compromised. Saline implants are filled with sterile saline and can be adjusted in volume during surgery; they are firmer and rippling may be more visible in thin patients. All silicone implants used in established cosmetic centres carry CE marking or FDA approval and are tested to international safety standards.

Incision approaches include the inframammary fold (most common, most direct access, best for precise pocket creation), periareolar (around the nipple edge, less visible scar but higher sensory nerve risk), transaxillary (through the armpit, no breast scar), and transumbilical (TUBA, through the navel — only possible for saline implants). Pocket placement options are subglandular (above the muscle, more natural movement but higher contracture risk), submuscular (beneath the muscle, better coverage in thin patients, lower contracture risk), and dual-plane (partially beneath the muscle, balances the advantages of both). Autologous fat transfer augmentation uses liposuction from donor sites followed by injection of processed fat; it adds modest volume (one cup size maximum), feels completely natural, but requires sufficient donor fat and has variable graft survival rates of 40 to 80%.

Patient satisfaction rates following breast augmentation are among the highest of any elective cosmetic procedure, with studies reporting 90 to 95% satisfaction at one to three years post-operatively. Improvements in breast volume, shape, and symmetry are immediate and lasting. Psychological benefits including improved body image, self-esteem, and sexual confidence have been documented in multiple prospective quality-of-life studies.

Modern implants have robust long-term safety profiles. The 15-year data for cohesive silicone gel implants show rupture rates of approximately 8 to 12% and capsular contracture rates of 10 to 20%, both manageable with revision surgery. Autologous fat transfer results are permanent where the grafted fat survives and are associated with no implant-related risks, though additional procedures may be needed to achieve the desired volume.

Capsular contracture — hardening of the scar tissue capsule around the implant — is the most common late complication, occurring in 10 to 20% of patients within 10 years. Grades III and IV contracture cause visible distortion and discomfort requiring surgical correction. Implant rupture (intracapsular or extracapsular) occurs in approximately 1 to 2% of implants per year; modern cohesive gel implants typically rupture silently and require MRI surveillance for detection. Infection occurs in approximately 1 to 2% of cases and may necessitate implant removal.

BIA-ALCL (breast implant-associated anaplastic large cell lymphoma) is a rare lymphoma linked specifically to textured surface implants; the estimated lifetime risk is approximately 1 in 2,500 to 1 in 25,000 with textured implants. Following regulatory action in multiple countries, many surgeons now prefer smooth implants. Changes in nipple sensation (increased or decreased) affect approximately 7 to 15% of patients. Breastfeeding is usually possible after augmentation, though periareolar incision carries a slightly higher risk of affecting lactation ducts compared with inframammary incisions.

Immediately after surgery, patients wear a surgical bra continuously for three to six weeks to support healing and maintain implant position. Drain tubes are used by some surgeons and removed within 24 to 48 hours. Most patients experience moderate soreness, tightness, and swelling for one to two weeks. Return to sedentary work is typically possible within five to seven days; return to exercise and heavy lifting requires four to six weeks.

Post-operative check-ups occur at one week (wound assessment), six weeks (scar review, range-of-motion assessment), and three to six months (final results assessment). Most patients feel their final result is apparent at three to six months once implants have settled (a process called implant "drop and fluff"). FDA and MHRA guidance recommends breast MRI surveillance every two to three years for silicone implant patients to monitor for silent rupture. Patients should continue standard mammographic screening, informing the radiographer of their implants so that specialised Eklund displacement views are used.

In the United States, breast augmentation with silicone implants costs $6,000 to $12,000 including surgeon fees, anaesthesia, operating room, and implants. In the United Kingdom under private care, the equivalent procedure ranges from £5,000 to £9,000. These costs are not covered by most health insurance plans as elective cosmetic procedures. Additional costs for revision surgery, if required, can be substantial.

Medical tourism for breast enhancement surgery is well-established in Thailand, Turkey, Czech Republic, Mexico, and Poland. In Thailand, board-certified plastic surgeons at JCI-accredited hospitals perform augmentation using US- and EU-approved implants for $3,000 to $5,000 all-inclusive. In Turkey, the cost ranges from $2,500 to $4,000. In Poland and the Czech Republic, EU-regulated care is available for £2,500 to £4,000. These destinations offer savings of 40 to 60% and are popular with patients from the UK, Australia, and North America. Patients should verify surgeon credentials (board certification in plastic surgery), hospital accreditation, and implant device regulatory approval status before proceeding.

Non-surgical alternatives to breast enhancement are limited. Padded bras and external breast forms (prostheses) provide a non-permanent cosmetic alternative. Vacuum suction devices have been marketed as a non-surgical enhancement method but have no credible evidence of lasting volume increase. Hormone-based approaches to breast growth are not evidence-based and carry systemic risks.

Autologous fat transfer offers a surgical alternative to implants for women seeking modest enhancement (typically one cup size) with a natural feel and no implant-related long-term concerns. It requires sufficient donor fat from liposuction sites and has variable graft retention. For women seeking primarily improved shape and projection with drooping rather than volume deficiency, mastopexy (breast lift) without implants may achieve their goals without implant-related considerations. The choice between augmentation, augmentation-mastopexy, mastopexy alone, and fat transfer is individualised based on breast examination, patient goals, and surgeon assessment.